magnesium sulfate has been researched along with Cavernitis, Fibrous in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bordovsky, MJ; Easterling, WJ; Fitch, WP; Mosier, M; Talbert, RL | 1 |
| Levine, L | 1 |
1 trial(s) available for magnesium sulfate and Cavernitis, Fibrous
| Article | Year |
|---|---|
Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study.
Topics: Administration, Topical; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Magnesium Sulfate; Male; Middle Aged; Penile Erection; Penile Induration; Quality of Life; Research Design; Treatment Outcome; Trifluoperazine; Verapamil | 2007 |
1 other study(ies) available for magnesium sulfate and Cavernitis, Fibrous
| Article | Year |
|---|---|
Comment on 'Topical verapamil HCL, topical trifluoroperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study'.
Topics: Administration, Topical; Adult; Double-Blind Method; Humans; Magnesium Sulfate; Male; Penile Erection; Penile Induration; Research Design; Trifluoperazine; Verapamil | 2007 |